KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Asset Utilization Ratio: 2012-2024

Historic Asset Utilization Ratio for Supernus Pharmaceuticals (SUPN) over the last 13 years, with Dec 2024 value amounting to 0.50.

  • Supernus Pharmaceuticals' Asset Utilization Ratio fell 0.82% to 0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49, marking a year-over-year decrease of 0.82%. This contributed to the annual value of 0.50 for FY2024, which is 22.71% up from last year.
  • Supernus Pharmaceuticals' Asset Utilization Ratio amounted to 0.50 in FY2024, which was up 22.71% from 0.41 recorded in FY2023.
  • In the past 5 years, Supernus Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.50 in FY2024 and a low of 0.36 during FY2021.
  • In the last 3 years, Supernus Pharmaceuticals' Asset Utilization Ratio had a median value of 0.41 in 2023 and averaged 0.43.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first decreased by 7.04% in 2021, then rose by 22.71% in 2024.
  • Supernus Pharmaceuticals' Asset Utilization Ratio (Yearly) stood at 0.39 in 2020, then dropped by 7.04% to 0.36 in 2021, then increased by 8.35% to 0.39 in 2022, then rose by 3.62% to 0.41 in 2023, then rose by 22.71% to 0.50 in 2024.